2-Ethylhexanoic Acid: Subchronic Oral Toxicity Studies in the Rat and Mouse

Groups of 10 male and 10 female Fischer 344 rats and B6C3F 1 mice were fed diets containing either 0.0, 0.1, 0.5 or 1.5% 2-ethylhexanoic acid (EHA) for 13 wk. Additional groups of 10 male and 10 female rats or mice, were fed either 0.0 or 1.5% EHA for 13 wk followed by a 4-wk recovery (non-treatment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Food and chemical toxicology 1998-05, Vol.36 (5), p.429-436
Hauptverfasser: Juberg, D.R., David, R.M., Katz, G.V., Bernard, L.G., Gordon, D.R., Vlaovic, M.S., Topping, D.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 436
container_issue 5
container_start_page 429
container_title Food and chemical toxicology
container_volume 36
creator Juberg, D.R.
David, R.M.
Katz, G.V.
Bernard, L.G.
Gordon, D.R.
Vlaovic, M.S.
Topping, D.C.
description Groups of 10 male and 10 female Fischer 344 rats and B6C3F 1 mice were fed diets containing either 0.0, 0.1, 0.5 or 1.5% 2-ethylhexanoic acid (EHA) for 13 wk. Additional groups of 10 male and 10 female rats or mice, were fed either 0.0 or 1.5% EHA for 13 wk followed by a 4-wk recovery (non-treatment) period. Based on food consumption and body weight, the EHA diets provided doses of 61, 303 or 917 mg/kg/day for male rats and 71, 360 or 1068 mg/kg/day for female rats. The EHA diets provided doses of 180, 885 or 2728 mg/kg/day for male mice and 205, 1038 or 3139 mg/kg/day for female mice. No mortality or significant clinical signs of toxicity were observed during the study. Body weights and food consumption of both rats and mice fed 1.5% EHA were lower beginning after the first week of treatment, consistent with a reduction in food consumption. Other groups were unaffected by treatment. After 13 wk, lower triglyceride levels occurred in male mice fed 1.5% EHA and female mice fed 0.5 or 1.5% EHA, but not in other groups. Cholesterol levels were higher in all male rat test groups and in female rats and male and female mice fed either 0.5 or 1.5% EHA, although this effect was reversible following a 28-day recovery period. The principal effects of EHA involved the liver or metabolic processes associated with the liver. The 0.5 and 1.5% diets in both rats and mice were associated with increased relative liver weight and histological changes in hepatocytes, specifically hepatocyte hypertrophy and reduced cytoplasmic vacuolization. Observed histopathological and clinical pathological changes were reversible following recovery. These results indicate that EHA does not produce persistent, overt toxicity in rats or mice following subchronic dietary exposure at concentrations up to 1.5% in feed. The no-observed-adverse-effect level (NOAEL) for male rats was 61 mg/kg/day and the no-observed-effect level (NOEL) for female rats was 71 mg/kg/day, while 180 and 205 mg/kg/day represent NOELs for male and female mice, respectively.
doi_str_mv 10.1016/S0278-6915(97)00168-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16550069</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278691597001683</els_id><sourcerecordid>16550069</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-7265ba0e26d2f15105588b8865e78df9bf65040643ed6cd3b18ce09e9a1bf7593</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotVZ_QiEHET2sJrvNx3qRUuoHVgq2nkM2maWR7W5NdqX9924_6NXTwMwzMy8PQn1K7imh_GFGYiEjnlJ2m4o70rZklJygLpUiiXjC6CnqHpFzdBHCNyFEUME7qJNyHg-o7KL3OBrXi02xgLUuK2fw0Dj7iGdNZha-KtvG1OsCz6u1M67e4FndWAcBuxLXC8Cfusa6tPijagJcorNcFwGuDrWHvp7H89FrNJm-vI2Gk8gMJK8jEXOWaQIxt3FOGSWMSZlJyRkIafM0yzkjA8IHCVhubJJRaYCkkGqa5YKlSQ_d7O-ufPXTQKjV0gUDRaFLaHMoyhkjhG9BtgeNr0LwkKuVd0vtN4oStZWodhLV1pBKhdpJVEm71z88aLIl2OPWwVo7vz7MdTC6yL0ujQtHLE4olWT7_mmPQSvj14FXwTgoDVjnwdTKVu6fIH-w2oxl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16550069</pqid></control><display><type>article</type><title>2-Ethylhexanoic Acid: Subchronic Oral Toxicity Studies in the Rat and Mouse</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Juberg, D.R. ; David, R.M. ; Katz, G.V. ; Bernard, L.G. ; Gordon, D.R. ; Vlaovic, M.S. ; Topping, D.C.</creator><creatorcontrib>Juberg, D.R. ; David, R.M. ; Katz, G.V. ; Bernard, L.G. ; Gordon, D.R. ; Vlaovic, M.S. ; Topping, D.C.</creatorcontrib><description>Groups of 10 male and 10 female Fischer 344 rats and B6C3F 1 mice were fed diets containing either 0.0, 0.1, 0.5 or 1.5% 2-ethylhexanoic acid (EHA) for 13 wk. Additional groups of 10 male and 10 female rats or mice, were fed either 0.0 or 1.5% EHA for 13 wk followed by a 4-wk recovery (non-treatment) period. Based on food consumption and body weight, the EHA diets provided doses of 61, 303 or 917 mg/kg/day for male rats and 71, 360 or 1068 mg/kg/day for female rats. The EHA diets provided doses of 180, 885 or 2728 mg/kg/day for male mice and 205, 1038 or 3139 mg/kg/day for female mice. No mortality or significant clinical signs of toxicity were observed during the study. Body weights and food consumption of both rats and mice fed 1.5% EHA were lower beginning after the first week of treatment, consistent with a reduction in food consumption. Other groups were unaffected by treatment. After 13 wk, lower triglyceride levels occurred in male mice fed 1.5% EHA and female mice fed 0.5 or 1.5% EHA, but not in other groups. Cholesterol levels were higher in all male rat test groups and in female rats and male and female mice fed either 0.5 or 1.5% EHA, although this effect was reversible following a 28-day recovery period. The principal effects of EHA involved the liver or metabolic processes associated with the liver. The 0.5 and 1.5% diets in both rats and mice were associated with increased relative liver weight and histological changes in hepatocytes, specifically hepatocyte hypertrophy and reduced cytoplasmic vacuolization. Observed histopathological and clinical pathological changes were reversible following recovery. These results indicate that EHA does not produce persistent, overt toxicity in rats or mice following subchronic dietary exposure at concentrations up to 1.5% in feed. The no-observed-adverse-effect level (NOAEL) for male rats was 61 mg/kg/day and the no-observed-effect level (NOEL) for female rats was 71 mg/kg/day, while 180 and 205 mg/kg/day represent NOELs for male and female mice, respectively.</description><identifier>ISSN: 0278-6915</identifier><identifier>EISSN: 1873-6351</identifier><identifier>DOI: 10.1016/S0278-6915(97)00168-3</identifier><identifier>PMID: 9662418</identifier><identifier>CODEN: FCTOD7</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Administration, Oral ; Alanine Transaminase - blood ; Animals ; Biological and medical sciences ; Body Weight - drug effects ; Caproates - toxicity ; Chemical and industrial products toxicology. Toxic occupational diseases ; Cholesterol - blood ; Eating - drug effects ; Female ; Liver - drug effects ; Liver - pathology ; Male ; Medical sciences ; Mice ; No-Observed-Adverse-Effect Level ; Organ Size - drug effects ; Rats ; Rats, Inbred F344 ; Toxicology ; Triglycerides - blood ; Various organic compounds</subject><ispartof>Food and chemical toxicology, 1998-05, Vol.36 (5), p.429-436</ispartof><rights>1997 Elsevier Science Ltd</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-7265ba0e26d2f15105588b8865e78df9bf65040643ed6cd3b18ce09e9a1bf7593</citedby><cites>FETCH-LOGICAL-c486t-7265ba0e26d2f15105588b8865e78df9bf65040643ed6cd3b18ce09e9a1bf7593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0278691597001683$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2311809$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9662418$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Juberg, D.R.</creatorcontrib><creatorcontrib>David, R.M.</creatorcontrib><creatorcontrib>Katz, G.V.</creatorcontrib><creatorcontrib>Bernard, L.G.</creatorcontrib><creatorcontrib>Gordon, D.R.</creatorcontrib><creatorcontrib>Vlaovic, M.S.</creatorcontrib><creatorcontrib>Topping, D.C.</creatorcontrib><title>2-Ethylhexanoic Acid: Subchronic Oral Toxicity Studies in the Rat and Mouse</title><title>Food and chemical toxicology</title><addtitle>Food Chem Toxicol</addtitle><description>Groups of 10 male and 10 female Fischer 344 rats and B6C3F 1 mice were fed diets containing either 0.0, 0.1, 0.5 or 1.5% 2-ethylhexanoic acid (EHA) for 13 wk. Additional groups of 10 male and 10 female rats or mice, were fed either 0.0 or 1.5% EHA for 13 wk followed by a 4-wk recovery (non-treatment) period. Based on food consumption and body weight, the EHA diets provided doses of 61, 303 or 917 mg/kg/day for male rats and 71, 360 or 1068 mg/kg/day for female rats. The EHA diets provided doses of 180, 885 or 2728 mg/kg/day for male mice and 205, 1038 or 3139 mg/kg/day for female mice. No mortality or significant clinical signs of toxicity were observed during the study. Body weights and food consumption of both rats and mice fed 1.5% EHA were lower beginning after the first week of treatment, consistent with a reduction in food consumption. Other groups were unaffected by treatment. After 13 wk, lower triglyceride levels occurred in male mice fed 1.5% EHA and female mice fed 0.5 or 1.5% EHA, but not in other groups. Cholesterol levels were higher in all male rat test groups and in female rats and male and female mice fed either 0.5 or 1.5% EHA, although this effect was reversible following a 28-day recovery period. The principal effects of EHA involved the liver or metabolic processes associated with the liver. The 0.5 and 1.5% diets in both rats and mice were associated with increased relative liver weight and histological changes in hepatocytes, specifically hepatocyte hypertrophy and reduced cytoplasmic vacuolization. Observed histopathological and clinical pathological changes were reversible following recovery. These results indicate that EHA does not produce persistent, overt toxicity in rats or mice following subchronic dietary exposure at concentrations up to 1.5% in feed. The no-observed-adverse-effect level (NOAEL) for male rats was 61 mg/kg/day and the no-observed-effect level (NOEL) for female rats was 71 mg/kg/day, while 180 and 205 mg/kg/day represent NOELs for male and female mice, respectively.</description><subject>Administration, Oral</subject><subject>Alanine Transaminase - blood</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Caproates - toxicity</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Cholesterol - blood</subject><subject>Eating - drug effects</subject><subject>Female</subject><subject>Liver - drug effects</subject><subject>Liver - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>No-Observed-Adverse-Effect Level</subject><subject>Organ Size - drug effects</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Toxicology</subject><subject>Triglycerides - blood</subject><subject>Various organic compounds</subject><issn>0278-6915</issn><issn>1873-6351</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotVZ_QiEHET2sJrvNx3qRUuoHVgq2nkM2maWR7W5NdqX9924_6NXTwMwzMy8PQn1K7imh_GFGYiEjnlJ2m4o70rZklJygLpUiiXjC6CnqHpFzdBHCNyFEUME7qJNyHg-o7KL3OBrXi02xgLUuK2fw0Dj7iGdNZha-KtvG1OsCz6u1M67e4FndWAcBuxLXC8Cfusa6tPijagJcorNcFwGuDrWHvp7H89FrNJm-vI2Gk8gMJK8jEXOWaQIxt3FOGSWMSZlJyRkIafM0yzkjA8IHCVhubJJRaYCkkGqa5YKlSQ_d7O-ufPXTQKjV0gUDRaFLaHMoyhkjhG9BtgeNr0LwkKuVd0vtN4oStZWodhLV1pBKhdpJVEm71z88aLIl2OPWwVo7vz7MdTC6yL0ujQtHLE4olWT7_mmPQSvj14FXwTgoDVjnwdTKVu6fIH-w2oxl</recordid><startdate>19980501</startdate><enddate>19980501</enddate><creator>Juberg, D.R.</creator><creator>David, R.M.</creator><creator>Katz, G.V.</creator><creator>Bernard, L.G.</creator><creator>Gordon, D.R.</creator><creator>Vlaovic, M.S.</creator><creator>Topping, D.C.</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>19980501</creationdate><title>2-Ethylhexanoic Acid: Subchronic Oral Toxicity Studies in the Rat and Mouse</title><author>Juberg, D.R. ; David, R.M. ; Katz, G.V. ; Bernard, L.G. ; Gordon, D.R. ; Vlaovic, M.S. ; Topping, D.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-7265ba0e26d2f15105588b8865e78df9bf65040643ed6cd3b18ce09e9a1bf7593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Administration, Oral</topic><topic>Alanine Transaminase - blood</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Caproates - toxicity</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Cholesterol - blood</topic><topic>Eating - drug effects</topic><topic>Female</topic><topic>Liver - drug effects</topic><topic>Liver - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>No-Observed-Adverse-Effect Level</topic><topic>Organ Size - drug effects</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Toxicology</topic><topic>Triglycerides - blood</topic><topic>Various organic compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Juberg, D.R.</creatorcontrib><creatorcontrib>David, R.M.</creatorcontrib><creatorcontrib>Katz, G.V.</creatorcontrib><creatorcontrib>Bernard, L.G.</creatorcontrib><creatorcontrib>Gordon, D.R.</creatorcontrib><creatorcontrib>Vlaovic, M.S.</creatorcontrib><creatorcontrib>Topping, D.C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Food and chemical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Juberg, D.R.</au><au>David, R.M.</au><au>Katz, G.V.</au><au>Bernard, L.G.</au><au>Gordon, D.R.</au><au>Vlaovic, M.S.</au><au>Topping, D.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>2-Ethylhexanoic Acid: Subchronic Oral Toxicity Studies in the Rat and Mouse</atitle><jtitle>Food and chemical toxicology</jtitle><addtitle>Food Chem Toxicol</addtitle><date>1998-05-01</date><risdate>1998</risdate><volume>36</volume><issue>5</issue><spage>429</spage><epage>436</epage><pages>429-436</pages><issn>0278-6915</issn><eissn>1873-6351</eissn><coden>FCTOD7</coden><abstract>Groups of 10 male and 10 female Fischer 344 rats and B6C3F 1 mice were fed diets containing either 0.0, 0.1, 0.5 or 1.5% 2-ethylhexanoic acid (EHA) for 13 wk. Additional groups of 10 male and 10 female rats or mice, were fed either 0.0 or 1.5% EHA for 13 wk followed by a 4-wk recovery (non-treatment) period. Based on food consumption and body weight, the EHA diets provided doses of 61, 303 or 917 mg/kg/day for male rats and 71, 360 or 1068 mg/kg/day for female rats. The EHA diets provided doses of 180, 885 or 2728 mg/kg/day for male mice and 205, 1038 or 3139 mg/kg/day for female mice. No mortality or significant clinical signs of toxicity were observed during the study. Body weights and food consumption of both rats and mice fed 1.5% EHA were lower beginning after the first week of treatment, consistent with a reduction in food consumption. Other groups were unaffected by treatment. After 13 wk, lower triglyceride levels occurred in male mice fed 1.5% EHA and female mice fed 0.5 or 1.5% EHA, but not in other groups. Cholesterol levels were higher in all male rat test groups and in female rats and male and female mice fed either 0.5 or 1.5% EHA, although this effect was reversible following a 28-day recovery period. The principal effects of EHA involved the liver or metabolic processes associated with the liver. The 0.5 and 1.5% diets in both rats and mice were associated with increased relative liver weight and histological changes in hepatocytes, specifically hepatocyte hypertrophy and reduced cytoplasmic vacuolization. Observed histopathological and clinical pathological changes were reversible following recovery. These results indicate that EHA does not produce persistent, overt toxicity in rats or mice following subchronic dietary exposure at concentrations up to 1.5% in feed. The no-observed-adverse-effect level (NOAEL) for male rats was 61 mg/kg/day and the no-observed-effect level (NOEL) for female rats was 71 mg/kg/day, while 180 and 205 mg/kg/day represent NOELs for male and female mice, respectively.</abstract><cop>Oxford</cop><cop>New York, NY</cop><pub>Elsevier Ltd</pub><pmid>9662418</pmid><doi>10.1016/S0278-6915(97)00168-3</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-6915
ispartof Food and chemical toxicology, 1998-05, Vol.36 (5), p.429-436
issn 0278-6915
1873-6351
language eng
recordid cdi_proquest_miscellaneous_16550069
source MEDLINE; Elsevier ScienceDirect Journals
subjects Administration, Oral
Alanine Transaminase - blood
Animals
Biological and medical sciences
Body Weight - drug effects
Caproates - toxicity
Chemical and industrial products toxicology. Toxic occupational diseases
Cholesterol - blood
Eating - drug effects
Female
Liver - drug effects
Liver - pathology
Male
Medical sciences
Mice
No-Observed-Adverse-Effect Level
Organ Size - drug effects
Rats
Rats, Inbred F344
Toxicology
Triglycerides - blood
Various organic compounds
title 2-Ethylhexanoic Acid: Subchronic Oral Toxicity Studies in the Rat and Mouse
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T18%3A45%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=2-Ethylhexanoic%20Acid:%20Subchronic%20Oral%20Toxicity%20Studies%20in%20the%20Rat%20and%20Mouse&rft.jtitle=Food%20and%20chemical%20toxicology&rft.au=Juberg,%20D.R.&rft.date=1998-05-01&rft.volume=36&rft.issue=5&rft.spage=429&rft.epage=436&rft.pages=429-436&rft.issn=0278-6915&rft.eissn=1873-6351&rft.coden=FCTOD7&rft_id=info:doi/10.1016/S0278-6915(97)00168-3&rft_dat=%3Cproquest_cross%3E16550069%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16550069&rft_id=info:pmid/9662418&rft_els_id=S0278691597001683&rfr_iscdi=true